- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03736434
Brain Connections and Blood Pressure
Brain Connections, Self-care and Blood Pressure in Black and African Americans With Problems With Memory
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this pilot randomized controlled study is to adapt a previously tested intervention to improve resting state network and blood pressure in 36 (n=12 intervention; n=12 attention control; n = 12 control) Black and African American older adults with early Alzheimer's disease and related dementia disorders and hypertension.
The study aims are to:
A.1. Establish the feasibility and acceptability of the intervention in Black and African Americans with Alzheimer's disease and related dementia disorders and hypertension.
H1: The intervention will be feasible and acceptable to Black and African Americans with Alzheimer's disease and related dementia disorders. Feasibility will be measured by recruitment, attendance, and attrition. Acceptability will be measured by a garnering feedback in a debriefing after each session.
A.2. Determine the effect size of the difference between the intervention, attention control, and control groups in resting state network connectivity and working memory and blood pressure to inform the sample size for the R01 trial.
H2: We hypothesize that compared to both control groups; the intervention group will have greater improvement in process measures of self-management mechanisms (self-efficacy, self-regulation, and emotion regulation), chronic stress, diet, and physical activity. The functional magnetic resonance imaging and blood pressure will be obtained at baseline and 3 months. The intervention group (Mindfulness + DASH) will have improved resting state network connectivity and blood pressure as compared to the attention control (2-hour group social time and brief lecture on a non-diet/mindfulness topic such as personal safety, fire safety, and disaster preparedness) and the control group (care as usual with no intervention). The Center for Cognitive and Behavioral Brain Imaging, Arts & Sciences co-investigators will analyze imaging data using their newly published statistical network model to quantify the subnetwork structures of the resting state network and evaluate changes of their topological properties.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Nursing
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of hypertension with or without medication use
- Diagnosis of Alzheimer's disease or related dementia disorder or, if no formal diagnosis of Alzheimer's disease, then a Self-Assessment Gerocognitive Evaluation score 17-10 or a Montreal Cognitive Assessment Screen 25-19
Exclusion Criteria:
- Unable to understand spoken English
- Expect to move out of the area within six months
- fMRI imaging contraindicated (history of shrapnel, metal in the body, heart pacemaker, heart defibrillator, metal in the eye, gunshot wound, or some types of metal elsewhere within the body such as certain surgical clips for aneurysms in the head, heart valve prostheses, electrodes, and some other implanted devices) or claustrophobia. However, the participant can be included in the study without fMRI.
- Self-reported history of a stroke
- <6 on the Brief Assessment of Understanding of the Study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness plus DASH group
Receives Mindfulness and DASH Diet education once a week for 8 weeks (2.5-hour sessions)
|
Mindfulness and DASH diet education will include a didactic presentation on stress, theoretical material related to mindfulness, the somatic mind/body connection, relaxation, yoga, meditation, self-awareness, and bodily cues relating to emotional reactivity.
Practices will include the body scan, gentle yoga movement, walking/sitting meditation, breathing, relaxation.
Additionally, daily 20 min individual practices are done at least 5x/week delivered via a compact disc player or on a preloaded device.
Each participant is asked to track his/her daily meditation practice and given a diary for adherence records.
A combination of didactic, experiential, and "hands-on" activities will be done to deliver DASH diet guidelines.
The attention control group will attend eight, 2.5 hours sessions on non-health topics such as personal safety, fire prevention, cold weather protection, disaster preparation, internet safety, aging in place, how to know when it's time to move and managing your money.
|
|
Active Comparator: Education Group
The sham intervention includes general education on non-health related topics such as fire-safety and learning how to dispose of medication properly, once a week for 8 weeks (2.5-hour sessions)
|
Mindfulness and DASH diet education will include a didactic presentation on stress, theoretical material related to mindfulness, the somatic mind/body connection, relaxation, yoga, meditation, self-awareness, and bodily cues relating to emotional reactivity.
Practices will include the body scan, gentle yoga movement, walking/sitting meditation, breathing, relaxation.
Additionally, daily 20 min individual practices are done at least 5x/week delivered via a compact disc player or on a preloaded device.
Each participant is asked to track his/her daily meditation practice and given a diary for adherence records.
A combination of didactic, experiential, and "hands-on" activities will be done to deliver DASH diet guidelines.
The attention control group will attend eight, 2.5 hours sessions on non-health topics such as personal safety, fire prevention, cold weather protection, disaster preparation, internet safety, aging in place, how to know when it's time to move and managing your money.
|
|
No Intervention: Control Group
Continue care as usual without intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Resting State Network
Time Frame: Baseline and 3 months
|
functional magnetic resonance imaging scans of brains utilizing and working memory test will be employed to measure change in resting state network
|
Baseline and 3 months
|
|
Change in Systolic Blood Pressure
Time Frame: Baseline and 3 months
|
Omron automatic blood pressure machine with small and large cuff sizes will be used to obtain blood pressure readings
|
Baseline and 3 months
|
|
Change in Diastolic Blood Pressure
Time Frame: Baseline and 3 months
|
Omron automatic blood pressure machine with small and large cuff sizes will be used to obtain blood pressure readings
|
Baseline and 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary Approaches to Stop Hypertension Questionnaire (DASH-Q) Change
Time Frame: Baseline and 3 months
|
DASH Q has 11 items focused on the consumption of DASH foods (e.g., fruits, nuts, and vegetables) in the past 7 days (Cronbach α = .83).
The reference range for the DASH Q was 0-105 with higher scores indicating greater adherence to DASH diet.
|
Baseline and 3 months
|
|
Cognitive and Affective Mindfulness Scale Change
Time Frame: Baseline and 3 months
|
The Cognitive and Affective Mindfulness Scale (Cronbach α = .77)17
has 12 questions (reference range 0-48, higher scores indicate greater mindfulness affect) on a Likert scale regarding daily experiences such as "I rush through activities without being really attentive to them."
|
Baseline and 3 months
|
|
Perceived Stress Scale Change
Time Frame: Baseline and 3 months
|
The Perceived Stress Scale has 10-items reference range 0-30 regarding stress over the past month (Cronbach α = 0.83).1The
cut point for moderate to high stress is 12 or more for persons aged 65 and older.
|
Baseline and 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathy D Wright, PhD, Ohio State University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018H0136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Mindfulness and DASH Diet Education
-
Case Western Reserve UniversityCompleted
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
National Health Research Institutes, TaiwanTaipei Veterans General Hospital, TaiwanUnknown
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Duke UniversityCompletedHypertension | Chronic Kidney DiseaseUnited States
-
Assiut UniversityNot yet recruitingDyslipidemia Associated With Type II Diabetes Mellitus
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedHypertension | Diabetes | Insulin ResistanceUnited States
-
University of MichiganCompletedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Penn State UniversityNational Cattlemen's Beef AssociationCompletedCardiovascular Disease | Metabolic SyndromeUnited States
-
Allama Iqbal Open University IslamabadCompletedEffect of Didactic Intervention Regarding (DASH) on HypertensionPakistan